Opus Genetics (IRD) Cash from Investing Activities (QoQ) (2010 - 2019)
Opus Genetics (IRD) Cash from Investing Activities (QoQ) (2010 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -104.12% |
| Sep 30, 2019 | 0.21% |
| Jun 30, 2019 | 150.78% |
| Mar 31, 2019 | -394.76% |
| Dec 31, 2018 | -45.42% |
| Sep 30, 2018 | 12.79% |
| Jun 30, 2018 | 8.39% |
| Mar 31, 2018 | 197.87% |
| Dec 31, 2017 | -202.21% |
| Sep 30, 2017 | 129.91% |
| Jun 30, 2017 | -1,510.17% |
| Mar 31, 2017 | -84.82% |
| Dec 31, 2016 | 345.47% |
| Sep 30, 2016 | -176.96% |
| Jun 30, 2016 | 423.23% |
| Mar 31, 2016 | 82.08% |
| Dec 31, 2015 | -161.46% |
| Sep 30, 2015 | 164.08% |
| Jun 30, 2015 | -37.79% |
| Mar 31, 2015 | 289.66% |